Cargando…

PPARγ ligands inhibit catabolic and inflammatory responses in articular joint cells

Detalles Bibliográficos
Autores principales:	Fahmi, H, Pelletier, J-P, Mineau, F, Martel-Pelletier, J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833826/ http://dx.doi.org/10.1186/ar836

Ejemplares similares

New strategies for the in vivo regulation of metalloprotease gene expression in osteoarthritis chondrocytes by inflammatory mediators
por: Pelletier, JP, et al.
Publicado: (2003)

Expression of PPARα, β, and γ in the Hartley guinea pig model of primary osteoarthritis
por: Ezzahra El Mansouri, Fatima, et al.
Publicado: (2012)

Egr-1 mediates the suppressive effect of IL-1 on PPARγ expression in human OA chondrocytes
por: Nebbaki, Salwa Sarah, et al.
Publicado: (2012)

Peroxisome proliferator-activated receptor gamma 1 expression is diminished in human osteoarthritis cartilage and is downregulated by IL-1β in articular chondrocytes
por: Afif, H, et al.
Publicado: (2007)

Regulation of collagenase-3 (MMP-13) gene and protein expression in human cartilage: when simple things get complicated
por: Martel-Pelletier, J, et al.
Publicado: (2003)

Implication of microRNA-140 in osteoarthritis
por: Martel-Pelletier, Johanne
Publicado: (2012)

Activation of peroxisome proliferator-activated receptor γ inhibits IL-1β-induced mPGES-1 expression in human synovial fibroblasts by interfering with Egr-1
por: Cheng, S, et al.
Publicado: (2004)

Galectin-3 in osteoarthritis: from a protective to a destructive role
por: Boileau, C, et al.
Publicado: (2004)

PPARγ deficiency results in severe, accelerated osteoarthritis associated with aberrant mTOR signalling in the articular cartilage
por: Vasheghani, Faezeh, et al.
Publicado: (2015)

Abnormal osteogenesis in osteoarthritis: gone with the Wnt?
por: Lajeunesse, Daniel, et al.
Publicado: (2012)

Peroxisome proliferator-activated receptor γ1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1β in articular chondrocytes
por: Afif, Hassan, et al.
Publicado: (2007)

Expression and regulation of microsomal prostaglandin E synthase-1 in human osteoarthritic cartilage and chondrocytes
por: Afif, H, et al.
Publicado: (2004)

Interleukin-1-induced cyclooxygenase-2 and inducible nitric oxide synthase expression in human OA chondrocytes is associated with histone H3K4 methylation
por: Chabane, N, et al.
Publicado: (2010)

The protective effect of licofelone on experimental osteoarthritis is correlated with the downregulation of gene expression and protein synthesis of several major cartilage catabolic factors: MMP-13, cathepsin K and aggrecanases
por: Pelletier, Jean-Pierre, et al.
Publicado: (2005)

15-Deoxy-Δ(12,14)-prostaglandin J(2 )inhibits IL-1β-induced cyclooxygenase-2 expression in human synovial fibroblasts through a histone deacetylase-independent mechanism
por: Farrajota, K, et al.
Publicado: (2004)

Activation of proteinase-activated receptor 2 in human osteoarthritic cartilage upregulates catabolic and proinflammatory pathways capable of inducing cartilage degradation: a basic science study
por: Boileau, Christelle, et al.
Publicado: (2007)

A 2-year evaluation of disease progression by quantitative magnetic resonance imaging in a large primary osteoarthritic patient population
por: Raynauld, J-P, et al.
Publicado: (2004)

Valproic acid suppresses interleukin-1β-induced microsomal prostaglandin E2 Synthase-1 expression in chondrocytes
por: Zayed, N, et al.
Publicado: (2010)

Oral treatment with PD-0200347, an α(2)δ ligand, reduces the development of experimental osteoarthritis by inhibiting the chondrocytes metalloproteases and inducible nitric oxide synthase gene expression and synthesis
por: Boileau, C, et al.
Publicado: (2004)

Human articular chondrocytes express 15-lipoxygenase-1 and -2: potential role in osteoarthritis
por: Chabane, Nadir, et al.
Publicado: (2009)

Skeletal involvement in the pathogenesis and outcomes of rheumatoid arthritis and osteoarthritis
por: Pelletier, Jean-Pierre
Publicado: (2012)

Prostaglandin D2 enhances interleukin -1beta- induced cyclooxygenase-2 expression in osteoarthritic cartilage
por: Zayed, N, et al.
Publicado: (2010)

Egr-1 mediates the suppressive effect of IL-1 on PPARg expression in human OA chondrocytes
por: Nebbaki, Sarah S, et al.
Publicado: (2012)

IDO-induced immunosuppressive tryptophan catabolism following primary HIV infection
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2014)

Intra-articular hyaluronan (Synvisc®, hylan G-F 20) for the treatment of first metatarsophalangeal joint osteoarthritis: a randomised, placebo controlled trial
por: Zammit, Gerard V, et al.
Publicado: (2011)

TIMP-3 inhibits aggrecan breakdown in pig articular cartilage stimulated with IL-1
por: Nagase, H, et al.
Publicado: (2003)

Poster 113: Epigenetic Regulation of PPARγ Rescues Articular Chondrocytes from Catabolic State Suggesting PPARγ as a Potential Target to Slow Down Progression of OA in Hip FAI
por: Kamenaga, Tomoyuki, et al.
Publicado: (2023)

Nutraceuticals as Ligands of PPARγ
por: Penumetcha, Meera, et al.
Publicado: (2012)

Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
por: Kulkarni, Ajit A., et al.
Publicado: (2012)

Altered phosphorylation of Syp may be responsible for abnormal insulin-like growth factor-1 signaling in human osteoarthritic osteoblasts
por: Lajeunesse, D, et al.
Publicado: (2003)

Levels of serum biomarkers from a two-year multicentre trial are associated with treatment response on knee osteoarthritis cartilage loss as assessed by magnetic resonance imaging: an exploratory study
por: Martel-Pelletier, Johanne, et al.
Publicado: (2017)

Defining a role for fibroblasts in the persistence of chronic inflammatory joint disease
por: Buckley, C, et al.
Publicado: (2005)

Kernel learning for ligand-based virtual screening: discovery of a new PPARγ agonist
por: Rupp, Matthias, et al.
Publicado: (2010)

Effects of PPARγ Ligands on Leukemia
por: Tabe, Yoko, et al.
Publicado: (2012)

Gastrointestinal Cytoprotection by PPARγ Ligands
por: Naito, Yuji, et al.
Publicado: (2010)

Degradation of small leucine-rich repeat proteoglycans by matrix metalloprotease-13: identification of a new biglycan cleavage site
por: Monfort, Jordi, et al.
Publicado: (2006)

Correction: Degradation of small leucine-rich repeat proteoglycans by matrix metalloprotease 13 - identification of a new biglycan cleavage site
por: Monfort, Jordi, et al.
Publicado: (2013)

Cytokine Reduction in the Treatment of Joint Conditions
por: Sipe, J. D., et al.
Publicado: (1994)

An alternate binding site for PPARγ ligands
por: Hughes, Travis S., et al.
Publicado: (2014)

Transcriptional regulation of the mPGES-1 gene in primary cultured articular chondrocytes
por: Bausero, P, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_egskj7k9lhvdcl4iq09mj97cpk